Skip to content

NeGIO Therapeutics

Active
Public limited company·Vervaardiging van farmaceutische grondstoffen· 3 yrs active
Chemin du Cyclotron 6 ·1348 Ottignies-Louvain-la-Neuve, Belgium
BE 0799.822.012
Watch Print / PDF
Turnover
EBIT margin
Net result€-608k+77.2%
Working capital€4.75M-8.5%

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of NeGIO Therapeutics is 1.7% (average). The 2025 annual accounts show equity of €4.75M and a net result of €-608k. Equity is shrinking by ~30.5% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2028. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
1.7% Average
0%0,5%1,5%4%10%≥25%
Young company +Multiple establishment units +Lower-risk legal form

Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?

Trust signals

3 signals
More than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Company registry (CBE)

Crossroads Bank
Activities
Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100
Primary activity highlighted.
Names & trade names
Legal nameFR NeGIO Therapeutics
AbbreviationFR NeGIO
Registered office
Chemin du Cyclotron 6
1348 Ottignies-Louvain-la-Neuve, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.